Status:
UNKNOWN
Protein and Magnesium in Ulcerative Colitis
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
University of Copenhagen
Conditions:
Inflammatory Bowel Diseases
Colitis, Ulcerative
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to improve the quality of nutritional therapy for patients admitted with Acute Severe Ulcerative Colitis (ASUC) treated with high-dose steroids. This study consists of two rand...
Detailed Description
Patients with Acute Severe Ulcerative Colitis (ASUC) may have an altered protein turnover due to inflammation, reduced dietary intake and/or accelerated protein loss. Despite this the level of dietary...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Cognizant
- Must speak or read Danish or participate in relevant communication in interpreting or translating the study material.
- Diagnosed with Acute Severe Ulcerative Colitis (ASUC) (documented in the patient journal)
- Admitted at "Lever-, Mave-, og Tarmsygdomme/ LMT" at Aarhus University Hospital and in medical treatment with high-dose intravenous steroid (Solumedrol 40 mg x 2 daily)
Exclusion
- Pregnant and/or lactating women
- Plasma creatinine \> 200 µmol/L (protein intervention only)
- Patients receiving tube- or parenteral feeding (protein intervention only)
- Receiving any kind of magnesium supplementation 6 months prior to inclusion (magnesium intervention only)
- Diagnosed with Type 1 or Type 2 Diabetes Mellitus (observational part only)
Key Trial Info
Start Date :
February 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05271838
Start Date
February 8 2022
End Date
July 1 2022
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus N, Denmark, 8200